Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
K.U. Kirchgässler
Sign up to set email alerts
8
Publications
7
Citation Statements Received
0
Citation Statements Given
How they've been cited
47
1
6
0
How they cite others
27
0
0
0
Affiliations
Roche (Switzerland)
,
University of Applied Sciences Biberach
Publications
Order By: Most citations
Analyse idéaltypique de carrières de patients.
Gerhardt
1
,
Kirchgässler
2
1987
sosan
Abstract
Show
17
0
3
0
Get access via publisher
Add to collection
Cite
Healthy survivor bias in patients with idiopathic pulmonary fibrosis in clinical registries
Vašáková
1
,
Šterclová
2
,
Moğulkoç
3
et al.
2021
3
1
3
0
Get access via publisher
Add to collection
Cite
La fragilité du quotidien : les processus de normalisation dans les maladies chroniques.
Kirchgässler
1
,
Matt
2
1987
sosan
Abstract
Show
20
0
0
0
Get access via publisher
Add to collection
Cite
Fenofibrate: A Safety Evaluation of a Large German Patient Population
Kirchgässler
1
1995
1
0
0
0
Get access via publisher
Add to collection
Cite
Change and continuity in patient theories of illness: The case of epilepsy
Kirchgässler
1
1990
Social Science & Medicine
6
0
0
0
Get access via publisher
Add to collection
Cite
Soziale Normalität und organische Pathologie bei Patienten mit Epilepsie: eine Langzeitperspektive
Kirchgässler
1
1989
0
0
0
0
Get access via publisher
Add to collection
Cite
Efficacy and tolerabily of 12 week treatment with 200 mg fenofibrate micronised once daily in dyslipidemic patients with coronary artery disease or at high risk for coronary artery disease (CAD)
März
1
,
Pfützner
2
,
Schmitz
3
et al.
1995
Atherosclerosis
0
0
0
0
Get access via publisher
Add to collection
Cite
1.P.169 Cross-country adaptation of pharmaco-economic evaluation: The example of micronised fenofibrate and simvastatin
Kirchgässler
1
,
Stahlheber
2
,
Viergutz
3
1997
Atherosclerosis
0
0
0
0
Get access via publisher
Add to collection
Cite
1